1 Introduction: Structure and Methodology

The essential facilities doctrine (hereinafter: the doctrine) is one of the most controversial aspects of competition law, with fierce supporters on one side and opponentsFootnote 1 on the other. Some argue that application of the doctrine opens markets to entry by new companies, which increases market competition, lowers prices, and increases the quality of productsFootnote 2 offered; while others contend that the possibility of mandatory access adversely affects companies’ incentives to invest and is an excessive restriction on the economic freedom of companies that control essential facilities.Footnote 3 Although the doctrine was initially intended to cover access to tangible facilities such as ports, bridges, railroads, etc., it was later extended to services and some intellectual property rights (IPRs), namely copyrights and patents.Footnote 4

In the European Union (EU), the criteria for applying the doctrine to IPRs differ from the criteria for applying it to tangible facilities and services. This paper examines the criteria for the application of the doctrine to IPRs in the EU, analyzes their peculiarities, and points out some ambiguities that still exist. All this with the aim of answering the research question: “What are the specifics of the intellectual property criteria in essential facilities cases and are these criteria applicable to Big Data?”

This paper is divided into four main parts. The first of these clarifies the basic elements and concepts with which the paper deals. It analyzes the doctrine and gives an overview of its genesis with a focus on intellectual property cases, and of the different criteria for its application as developed by the ECJFootnote 5 in its jurisprudence, where three different groups of criteria can be identified. The second part examines the specificities of IPRs as essential facilities, analyzing the relationship between competition law and IPRs, as well as the new product and technical progress conditions used to decide whether an IPR is an essential facility, pointing out their semantic indeterminacy and the problems in their practical application. The third part of the paper explores the possibilities for applying intellectual property criteria to Big Data. First, it is pointed out that recent legislative developments at the EU and national levels prove that Big Data can be an essential facility, while at the same time several peculiarities of Big Data compared to other essential facilities – tangible and intangible – are identified. This part of the paper argues that intellectual property criteria should not be applied indiscriminately to Big Data, as a set of Big Data is not necessarily protected by copyright. Moreover, due to the characteristics of Big Data – namely its lack of intrinsic value – and the markets driven by Big Data – in particular their innovative and propulsive nature – it is not appropriate to indiscriminately apply the new product and technical progress conditions in all cases where Big Data is the alleged essential facility. The fourth and final part of the paper summarizes the findings to answer the research question posed above.

The central research methods on which this paper is based are the normative-dogmatic method, used for analyzing the relevant factors as they are (de lege lata), and the axiological method, which is used for analyzing the adequacy of the criteria for activating the doctrine beyond the limits of existing general and abstract acts and case law (de lege ferenda). To a lesser extent, the comparative method is also used to analyze the position of Big Data as an essential facility in different legal systems. Within the three core research methods mentioned above, several instrumental methods are applied, namely the methods of collecting and analyzing information and discarding irrelevant information; the methods of description, classification, and abstraction; the methods of induction and deduction; and analytical and logical reasoning.Footnote 6

2 Setting the Scene

2.1 The Essential Facilities Doctrine

The doctrine is an “idea that the owner of a facility which is not replicable by the ordinary process of innovation and investment, and without access to which competition on a market is impossible or seriously impeded has to share it with a rival.”Footnote 7 It was first developed by the US Supreme Court in the 1912 Terminal Railroad Combination caseFootnote 8 and transplanted into the EU legal system in the early 1970s. By that time it was already losing traction in the US, where it was heavily criticized by the Chicago school of competition analysis and branded as one of the most problematic, incoherent, and uncontrollable elements of competition law.Footnote 9 The doctrine was de facto banned from the US legal system by the Supreme Court’s 2004 Trinko ruling, which cited, inter alia, Areeda’s seminal article “Essential facilities: an epithet in need of limiting principles.”Footnote 10 However, the doctrine flourished in the EU, where the German ordoliberal school of economics is a strong influence.Footnote 11 A wide range of tangible and intangible facilities have been deemed essential under the case law of the ECJ and the European Commission (EC), such as chemicals necessary for the production of other chemicals,Footnote 12 tangible and intangible airport infrastructure,Footnote 13 ports,Footnote 14 rail infrastructure,Footnote 15 and newspaper delivery services.Footnote 16 Importantly, the status of an essential facility has also been accorded to IPRs.Footnote 17 The doctrine can be invoked in situations involving two vertically related markets, one upstream and one downstream, where the product of the upstream market is an essential input to the activities in the downstream market. In other words, activity in the downstream market is not possible without access to the product of the upstream market because there are no actual or potential substitutes for it. Since refusing to supply (or grant access to) an essential input is a form of abuse of market dominance, the company refusing access must be dominant in the upstream market for the doctrine to apply. At the same time, it must also be at least present on the downstream market.Footnote 18

2.2 Criteria for the Application of the Essential Facilities Doctrine

Despite the frequent application of the doctrine by the ECJ and the EC, especially from the 1980s to the early 2000s, no single set of criteria for applying the doctrine has developed. Rather, the criteria for its application vary from case to case and from facility to facility. A careful analysis of the relevant case law, however, reveals that there are broadly three types of criteria for applying the doctrine, depending on the nature of the facility in question.

2.2.1 The Bronner Criteria

Although the criteria set forth by the ECJ in its Bronner ruling have only been fully applied in a handful of cases,Footnote 19 they are the gold standard in essential facility cases and traditionally form the starting point of any analysis. In the Bronner case newspaper delivery services operated by the Mediaprint publishing company, which had a 46% share of the Austrian daily newspaper market (downstream market), were the alleged essential facility. Oskar Bronner, publisher of the competing daily newspaper “Der Standard,” demanded access to the newspaper delivery services, claiming that they were an essential facility that was indispensable for competition on the downstream market. The ECJ set out an exhaustive list of conditions that must be met for a facility to be considered essential and, as such, subject to the doctrine’s obligations. Accordingly, (i) the refusal to supply the facility must preclude all competition on the downstream market, (ii) there must be no objective justification for the refusal, and (iii) the facility must be indispensable for the activity on the downstream market, i.e., there must be no actual or potential substitutes.Footnote 20 The latter condition built on the ECJ’s ruling in Night Services, which held that a facility was indispensable only if there was no substitute for it. The Bronner ruling reflects the ECJ’s strong preference for competition for the market as opposed to competition in the market,Footnote 21 and accordingly sets high standards for the application of the doctrine. It can be concluded that the Bronner criteria apply to traditionalFootnote 22 tangible facilities as well as services, as confirmed by the ECJ in its 2021 ruling in Slovak Telekom.Footnote 23 Therein, the ECJ ruled that the Bronner criteria were not applicable in the case at hand, as access to the alleged essential facility (local loop) was already guaranteed by ex ante regulation, which, a contrario, means that the Bronner criteria are applicable in the absence of such regulation.Footnote 24

2.2.2 The Magill and IMS Health Criteria and Intellectual Property Rights

For about 15 years after the doctrine was introduced into the EU legal system the status of an essential facility was granted only to tangible facilities and services. However, this changed with the 1988 ECJ judgments of Volvo v. VengFootnote 25 and Renault v. Maxicar.Footnote 26 The factual situation was similar in both cases. The owners of design rights for automotive spare parts (Volvo and Renault) refused to grant licenses for the manufacture, import, and sale of spare parts to independent manufacturers without their consent, which, according to the independent manufacturers, constituted an abuse of market dominance. The ECJ concluded that the “authority of a proprietor of a protective right in respect of an ornamental model to oppose the manufacture by third parties, for the purposes of sale on the internal market or export, of products incorporating the design or to prevent the import of such products manufactured without its consent in other Member States constitutes the substance of his exclusive right.”Footnote 27 Thus, refusal to license does not constitute an abuse of dominance per se. However, refusal to license may constitute an abuse of market dominance if it leads to abusive conduct, such as “an arbitrary refusal to deliver spare parts to independent repairers, the fixing of prices for spare parts at an unfair level or a decision no longer to produce spare parts for a particular model even though many cars of that model remain in circulation, provided that such conduct is liable to affect trade between Member States.”Footnote 28

Neither judgment developed abstract criteria for assessing the character of IPRs as essential facilities; this was first done in the ECJ’s Magill judgment, where the alleged essential facility were weekly television programs of individual television stations in the Republic of Ireland used to create a consolidated television program of all television stations in the Republic of Ireland. Although it was not entirely clear throughout the proceedings that the alleged essential facility was in fact protected by IPRs,Footnote 29 the ECJ introduced the new product condition. This condition is only applicable in cases where the alleged essential facility is protected by IPRs and requires that access to the essential facility (its licensing) is necessary for the offering of a new product for which there is at least potential consumer demand.Footnote 30 The criteria for the doctrine’s application in intellectual property cases were further elaborated in the Ladbroke ruling,Footnote 31 stating that the doctrine cannot be invoked if the controlling company is not at least active in the downstream market and/or if the company seeking access has a dominant position in that market.Footnote 32 The ECJ reaffirmed and developed the Magill criteria in its judgment in IMS Health, with the alleged essential facility being the 1860 brick structure, protected by IPRs and developed by the company IMS Health. The 1860 brick structure was used to monitor information on the sale of pharmaceutical products in Germany and became an industry standard. It was therefore not possible to compete on the downstream market (sales of pharmaceutical products in Germany) without having access to this facility. The ruling states that a facility protected by IPRs is essential within the meaning of the doctrine if three cumulative criteria are met, namely that the refusal “prevents the emergence of a new product for which there is potential consumer demand, that it is unjustified, and that it is likely to foreclose all competition in a secondary market.”Footnote 33 It remains unclear, however, whether the company holding the IPR could successfully argue that the temporary monopoly on the use of the idea it protects is objectively justified because it is necessary to cover the research and development costs incurred.Footnote 34

2.2.3 The Microsoft Criteria

Prior to the ECJ’s 2007 Microsoft ruling, the criteria for applying the doctrine to both tangible facilities and services and to facilities protected by IPRs were relatively clear. All of this changed with the aforementioned judgment, which led to continued uncertainty regarding the criteria necessary for the application of the doctrine. As a result, the judgment marked the beginning of an almost 15-year hiatus in the application of the doctrine by both the EC and the ECJ.Footnote 35

Microsoft had a 90% market share in the client PC operating system market (upstream market) and refused to grant the interoperability information that companies needed to compete in the work group server operating system market (downstream market) as it entered that market itself. Since Windows client PC operating systems were an industry standard, interoperability with those systems was necessary to operate in the workgroup operating system market. The alleged essential facility was interoperability information (protocols) protected by IPRs. The ECJ upheld the EC’s decisionFootnote 36 in all major points and ruled that Microsoft had abused its dominant position in the upstream market. In addition, the ECJ modified the IMS Health criteria in two important respects. First, it discarded the new product condition and replaced it with the technical progress condition, stating that “the circumstance relating to the appearance of a new product, as envisaged in Magill and IMS Health, paragraph 107 above, cannot be the only parameter which determines whether a refusal to license an intellectual property right is capable of causing prejudice to consumers within the meaning of Art. 82(b) EC. As that provision states, such prejudice may arise where there is a limitation not only of production or markets, but also of technical development.”Footnote 37 In other words, it was no longer necessary to show that the refusal to license prevented the emergence of a new product, but only that it impeded technical progress. Second, the ECJ also discarded the requirement that the refusal to license precludes all competition in the downstream market, finding that it was only necessary that the refusal precludes all effective competition in that market.Footnote 38

3 Intellectual Property Rights as Essential Facilities

3.1 Competition Law and Intellectual Property Law

Both competition law and intellectual property law aim to improve consumer welfare, albeit with different approaches. While competition law aims to improve market efficiency,Footnote 39 leading to lower prices and higher quality products, intellectual property law excludes third parties from using an idea protected by IPRs. This creates a de facto temporary monopoly on the use of that idea by its creator, protecting the creator’s incentives to invest in future innovations that lead to lower prices and better product quality,Footnote 40 while also increasing the incentives for competing companies to invest in the development of new competing products (substitutes). Before the idea protected by IPRs enters the public domain, there is a collision between the interest of the originator of the idea in its monopolistic exploitation and the interests of third parties to gain access to it themselves. This collision is addressed in part by the doctrine.Footnote 41

In the EU, the criteria for applying the doctrine in intellectual property cases have traditionally been stricter than the criteria for applying it in other essential facility cases, because they take into account the particular interest of the originator of the idea to monopolize the idea that is the result of his investment in the development of innovations.Footnote 42 In intellectual property cases, therefore, the doctrine can be applied only in situations where IPRs do not provide incentives for innovation, but rather hinder it. If this is the case, the ECJ and EC seek to strike a fair balance between the legitimate interests of the IPR holder and the company seeking access,Footnote 43 while taking the impact of mandated access to the IPR-protected idea on incentives to invest in innovation into account.Footnote 44

Despite all the above, I believe that the introduction of stricter criteria for the application of the doctrine in intellectual property cases is not justified because the criteria for the doctrine’s application to tangible facilities and services, as set forth in the Bronner ruling, already require a high threshold being met. It is undisputed that the development of new ideas protected by IPRs may require significant investment and that it is both economically and socially desirable to protect the incentives of companies to invest in innovation. However, the creation of tangible facilities and services also involves high start-up costs. Consider, for example, the cost of building a port or establishing a nationwide newspaper delivery system. In addition, it is not easy to infringe IPRs on an industrial scale, as this requires a significant investment of time, financial resources, and know-how that most companies do not have.Footnote 45

3.2 On the New Product and Technical Progress Conditions

As explained above, the main difference between the criteria for applying the doctrine in intellectual property cases, as opposed to cases involving access to tangible facilities and services, is the addition of the new product condition, which was discarded in favor of the technical progress condition in the Microsoft ruling. Under the new product condition, the interest of the company seeking access outweighs the interest of the IPR holder only if the requesting company will offer a new product based on the idea protected by the IPR, for which there is actual or at least potential consumer demand, i.e., in situations where the mandated access will promote innovation.Footnote 46 In my view, the term “new product” is semantically vague and open to interpretation, as it can be difficult to determine whether the product offered is really “new” or just an improvement on an existing product.Footnote 47 The difficulties in applying the new product condition are exacerbated by the fact that there is no legal or economic definition of a “new product.”Footnote 48 An analysis of existing case law leads to the conclusion that for a product to be a “new product” it is not required that it opens up a new, previously non-existent market, but rather that it differs from the already existing product in its essential characteristics. However, an entirely new market may be opened up – as demonstrated in the Magill case – in which the market for consolidated weekly television programs could only be opened up after the acquisition of the essential facility in question (weekly television programs from individual television stations). The situation was different in the IMS Health and Microsoft cases, where the two downstream markets existed beforehand, but it was not possible for companies other than IMS Health and Microsoft to operate on them, because the two companies had a de facto monopoly on the use of the essential facility, which was also an industry standard.Footnote 49

In my view, the scope of the technical progress condition assumed in the Microsoft ruling is even more vague and ambiguous than that of the new product condition. First, it is unclear whether the condition was exclusively tailored to the present case, which involved a very specific state of affairs, or whether it is more generally applicable. And even if it were generally applicable, in the absence of relevant case law on the subject it is unclear what level of technical progress would be sufficient for the doctrine to apply. In other words, it is not clear whether a minimum degree of technical progress would be sufficient or whether the technical progress would have to be substantial.

4 Criteria for the Assessment of Big Data under the Essential Facilities Doctrine

4.1 Big Data as Essential Facility

Despite the importance of Big Data, there is no universally accepted definition of what Big Data actually is. However, this paper adopts the definition of the EC, which refers to Big Data as “large amounts of different types of data produced with high velocity from a high number of various types of sources, whose handling requires new tools and methods, such as powerful processors, software and algorithms.”Footnote 50, Footnote 51 The most important characteristics that distinguish Big Data from “normal” data are its volume, its diversity, and the speed with which new data is collected. Big Data includes structured and unstructured data from a variety of sources, such as social media, IoT devices and enterprise applications. The data generated by these sources is huge, and is growing at an exponential rate.Footnote 52 Big Data is very different from traditional essential facilities – both tangible facilities and services, as well as IPRs – because both its marginal valueFootnote 53 and value over timeFootnote 54 are decreasing and it is generally a non-rivalrous facility.Footnote 55 Moreover, Big Data has no intrinsic value, meaning that it is, per se, useless. The true value of Big Data lies in the information it contains, which are obtained using advanced analytical tools. Therefore, before analyzing a set of Big Data,Footnote 56 only more or less accurate guesses about the nature of the information it contains are possible. Although Big Data is omnipresent in most cases and can theoretically be collected by all market participants, it is not widely available because collecting and processing Big Data involves extremely high (prohibitive) investments.Footnote 57 However, once such capabilities are established, the economies of scale associated with Big Data collection and processing are virtually infinite, and the economic efficiency of data processing grows exponentially as the total amount of data collected and processed increases.Footnote 58 However, one can also imagine situations where Big Data is neither omnipresent nor widely available because a single company controls all relevant data, as in the cases of PeopleBrowsrFootnote 59 and HiQ LabsFootnote 60 in the US.Footnote 61

The EC has avoided taking a clear position on the possibility that Big Data is an essential facility, although it has had the opportunity to do so in the Facebook/WhatsApp,Footnote 62Google/DoubleClickFootnote 63 and Telefónica UK/Vodafone UK/Everything Everywhere/JVFootnote 64 cases. However, legal developments at the EU level and in several Member States clearly recognize that Big Data can be an essential facility. For example, the EU Digital Markets Act requires gatekeepers to, inter alia, “provide business users and third parties authorized by a business user, at their request, free of charge, with effective, high-quality, continuous, and real-time access to, and use of, aggregated and non-aggregated data, including personal data, that is provided for or generated in the context of the use of the relevant core platform services or services provided together with, or in support of, the relevant core platform services by those business users and the end users engaging with the products or services provided by those business users.”Footnote 65 In addition, the Tenth Amendment to the German Act against Restraints of CompetitionFootnote 66 introduced a provision clarifying that (Big) DataFootnote 67 may be an essential facility,explicitly extending the definition of abuse of a dominant position to situations where the dominant company refuses access to sets of dataFootnote 68 it controls. Accordingly, the provision of Art. 19, para. 4 provides the basis for data access claims by stating that: “An abuse (of market dominance) exists in particular if a dominant undertaking as a supplier or purchaser of a certain type of goods or commercial services refuses to supply another undertaking with such a good or commercial service for adequate consideration, in particular to grant it access to data, networks or other infrastructure facilities, and if the supply or the granting of access is objectively necessary in order to operate on an upstream or downstream market.” In addition, under the Tenth Amendment, Art. 20, para. 1a of the said act clarifies that a position of relative market powerFootnote 69 “may also arise from the fact that an undertaking is dependent on accessing data controlled by another undertaking in order to carry out its own activities.” For a company that has relative market power, the provisions of Art. 19, para. 1 in conjunction with Art. 19, para. 2, point 1, which prohibit the abuse of market dominance, apply.Footnote 70 It can be concluded that the Tenth Amendment of the German Act against Restraints on Competition introduced the legal basis for data access claims both for cases where the controlling company enjoys a position of market dominance as well as where it only has relative market power. It does so by relying on the doctrine, confirming that sets of data can be an indispensable input for activity on a downstream market.

4.2 Application of the Intellectual Property Rights Criteria for the Assessment of the Nature of Big Data as an Essential Facility

As noted above, both the EC and the ECJ have yet to confirm the possibility that a set of Big Data constitutes an essential facility. Therefore, it is not clear which of the established criteria for evaluating the nature of a facility as essential (Bronner, IMS Health or Microsoft) should be used in such cases. Below, I argue that the criteria for assessing the nature of IPRs as essential facilities are not appropriate, although they were applied and to some extent reformulated in the Microsoft case, which involved digital markets.Footnote 71

4.2.1 Big Data Is Not Necessarily Protected by Copyright

It must first be noted that in practice, the doctrine was only applied to facilities protected by patents and copyrights, and not by other IPRs.Footnote 72 Despite this, when referring to the conditions for the application of the doctrine to patents and copyrights, the term “intellectual property conditions” is used in this paper, thus following the general usage as found in literature.Footnote 73 Moreover, due to its specificities a set of Big Data could only be protected by copyright in most cases.Footnote 74 Despite the lack of academic discourse and case law on this topic, it is my opinion that Big Data as a huge amount of structured and unstructured data does not, per se, meet the criteria required for copyright protection. However, depending on the nature of the data and how it was created and collected, copyright protection could extend to Big Data in certain situations.Footnote 75 This would be the case if the set of Big Data in question was unique and was created by the company’s own research and development efforts. In other words, only Big Data in the form of a set of Big Data created by some kind of creative effort that goes beyond the mere collection and classification of the data it consists of could be protected by copyright.

The IMS Health and Microsoft criteria were developed specifically with the goal of safeguarding facilities protected by copyrights and patents. In terms of a teleological interpretation, I do not believe it is appropriate to extend the reach of these criteria beyond their intended scope to also apply them to alleged essential facilities, which are not protected by either copyrights or patents. Thus, the IMS Health and Microsoft criteria could apply to Big Data if it is in the form of a set of Big Data created by some sort of creative input. Whether or not this is the case depends, of course, on the specifics of each such set. However, it is possible to rely on the Database DirectiveFootnote 76 for further clarification.Footnote 77

According to the Database Directive, a database enjoys copyright protection if the “selection or arrangement of its content, constitutes the author’s own intellectual creation,”Footnote 78 with recital 16 of the said Directive clarifying that “no criterion other than originality in the sense of the author's intellectual creation should be applied to determine the eligibility of the database for copyright protection, and in particular no aesthetic or qualitative criteria should be applied.” If a dataset is not protected by copyright, it can nevertheless be covered by the Database Directive, but only if the data are “arranged in a systematic or methodical way and individually accessible by electronic or other means.”Footnote 79 If the creation of the said database represents a “qualitatively and/or quantitatively substantial investmentFootnote 80 in either the obtaining, verification, or presentation of the contents,”Footnote 81 this database enjoys sui generis protection. The Database Directive thus establishes a two-tiered approach to the IPR protection of databases, which may be protected either by copyright, sui generis database protection, or both.Footnote 82 Thus, if a database does not meet the criteria of originality required for copyright protection, it may still be safeguarded by the sui generis system of protection if it represents a substantial investment in the collection, verification, and presentation of information. While there are some similarities between copyright and sui generis protection of databases, there are also “significant differences between the rights, especially in terms of subsistence, duration and infringement.”Footnote 83 The exact content of sui generis protection for databases will not be analyzed further, as it has already been the subject of extensive theoretical discussion,Footnote 84 but it should be noted that the sui generis protection system does not protect a database on the basis of its originality, but rather on the basis of the “qualitatively and/or quantitatively substantial investment in either the obtaining, verification, or presentation of the contents.”Footnote 85 This may lead to a situation where there are two comparable databases created by two different companies, one protected by the sui generis regime and the other not, because the first was the result of a qualitatively and/or quantitatively substantial investment, while the second was not.Footnote 86

Considering that the Database Directive provides that “a database enjoys copyright protection if the selection or arrangement of its content, constitutes the author’s own intellectual creation,” it can be inferred by analogyFootnote 87 that the originators of a set of Big Data must in some way, as the ECJ held in Bezpečnostní softwarová asociaceFootnote 88 and Infopaq International,Footnote 89 “express creative ability in an original manner by making free and creative choices,” for the said set of Big Data to be protected by copyright. In the absence of relevant case law on the originality of sets of Big Data, we can again resort to the analogy with databases. In Football Dataco,Footnote 90 the ECJ clarified the concept of originality in databases, concluding that a database constitutes the author’s own intellectual creation if “the selection or arrangement of the data which it contains amounts to an original expression of the creative freedom of its author”Footnote 91 which is not the case when “the setting up of the database is dictated by technical considerations, rules or constraints which leave no room for creative freedom.”Footnote 92 I believe that if the above conditions are met by a set of Big Data, it fulfils the criteria for copyright protection.

4.2.2 On the New Product and Technical Progress Conditions

As explored above, the classic criteria (Magill and IMS Health) for applying the doctrine in intellectual property cases require that access to the facility is necessary for the applicant company to offer a new product for which there is actual or at least potential consumer demand. In the case of IPRs whose licensing is requested under the doctrine, it is not difficult to foresee and even prove their necessity for the offering of a particular new product. In Magill, for example, it was clear that access to each television station’s television program was necessary to assemble a consolidated television program of all television stations, which did not yet exist and thus constituted a new product. Similarly, in the case of IMS Health, access to the 1860 brick structure was necessary to provide services in the market for the sale and distribution of pharmaceutical products (downstream market). In other words, the economic value of each IPR is known in advance to the companies requesting access before access is granted. Thus, they can argue that the new product condition is met. As mentioned earlier, it is different with Big Data, as it has no intrinsic value per se – its economic value is derived from the information it contains. However, in some cases the exact nature of this information cannot be known in advance before the set of Big Data in question is subjected to analysis with advanced analytical tools. In this context, it is necessary to distinguish two specific positions, one in which it is possible for companies to know in advance what kind of information (but not also the exact information) a set of Big Data contains, and one in which this is not the case. It is important to keep in mind that Big Data is characterized by constant change in terms of variety and scope. New data is constantly being generated, and the information it contains can be dynamic, requiring real-time analysis to gain commercially relevant information. In some cases, trying to know the information in a set of Big Data before it is analyzed could therefore be equal to trying to predict the future. In addition, extracting useful information from a set of Big Data can be highly contextual, meaning that the degree to which the information is useful depends on the circumstances in which it was generated. Contextual elements such as user behavior, environmental factors, or temporal considerations often emerge only during the analysis process, making preemptive insight difficult. Furthermore, with Big Data, there are often complex relationships between data points that are not apparent without analysis with advanced analytics tools. These complex relationships, such as correlations, patterns, or causalities, can unearth (commercially) important insights. However, in certain situations, the information contained in a set of Big Data can be predicted more or less accurately. Examples include sets of Big Data related to various loyalty programs where customers use loyalty cards or provide their personal information during transactions in supermarkets. It is known that sets of Big Data created in this way contain information about the purchased products, transaction amounts, and customer demographics. Another example are sets of Big Data created by fitness tracking apps that collect data about users’ exercise routines, sleep patterns, heart rates, and other health data. Ahead, it is also known that a set of Big Data on financial transactions contains information about, inter alia, purchases, deposits, and withdrawals.

It can therefore be concluded that it is possible to merely guess (more or less accurately) the nature of the information contained in a set of Big Data in some situations. Companies claiming access to Big Data by invoking the doctrine are in my view thus not always able to coherently argue that the set of Big Data in question is essential to the offering of a particular product that does not yet exist, since it is not clear whether this is the case or not. I believe that the applicability of the new product condition should therefore depend on whether it is known in advance what kind of information the analyzed set of Big Data contains (but not also the exact information itself). If this is the case, there is nothing to prevent the use of the new product condition. However, if this is not the case, the new product condition should not apply.

It would be easier for companies to argue that a certain set of Big Data is required to achieve technical progress, since the technical progress condition is easier to fulfil than the new product condition. Moreover, rapid and propulsive technical progress is one of the hallmarks of markets driven by Big Data, and in my opinion any new market development would therefore also represent at least some kind of technical progress.

To summarize, I believe that the indiscriminate application of both the new product condition and the technical progress condition in cases of access to Big Data based on the doctrine seems unwarranted. The new product condition should be applied only if the nature of the information contained in a set of Big Data is known in advance (before it is analyzed). If this is not the case, the new product condition should not be applied, as in such positions companies cannot predict whether access to a particular set of Big Data would enable them to offer a new product.Footnote 93 With regard to the technical progress condition, on the other hand, it can be assumed that any development in markets driven by Big Data represents at least some kind of technical progress, since these markets are characterized by rapid and propulsive technical development.

5 Findings

An analysis of the ECJ’s case law reveals three distinct sets of criteria for applying the doctrine: the Bronner criteria, used in cases involving tangible facilities and services; the IMS Health criteria, used in cases involving IPRs; and the Microsoft criteria, whose scope remains unknown in the absence of subsequent case law. Although the doctrine was developed primarily for assessing whether tangible facilities and services are essential facilities, the ECJ extended its reach to IPRs in the 1988 judgments of Volvo v. Veng and Renault v. Maxicar. Both rulings upheld the right of the holder of IPRs to exercise them monopolistically, but at the same time indicated that refusal to license may constitute an abuse of a market dominance if it leads to abusive conduct. The criteria for applying the doctrine to IPRs were systematically set out in the Magill and IMS Health judgments. The most important difference from the Bronner criteria is the addition of the new product condition, which further strengthens the position of the company controlling the essential facility. Thus, the doctrine can be applied to IPRs only if they do not promote innovation, but rather impede it. After the IMS Health ruling, it was relatively clear under what circumstances the doctrine could be applied in cases involving different types of alleged essential facilities. However, this changed with the ECJ’s Microsoft judgment, which involved interoperability information protected by IPRs as the alleged essential facility. The ruling abandoned the traditional intellectual property criteria and replaced the new product condition with the technical progress condition. Moreover, it did not require that the refusal to license eliminates all competition in the downstream market, but only effective competition. In the absence of subsequent case law, the scope of the Microsoft criteria is unknown. It is therefore unclear whether the Microsoft criteria were tailored to the present case, which involved a very specific set of facts, or whether their applicability is broaderFootnote 94 or even general. Regardless of which criteria (IMS Health or Microsoft) are applied in intellectual property cases, they are much more stringent than the criteria that apply in cases involving tangible facilities and services. In my opinion this is unwarranted, as the Bronner criteria already offer companies controlling alleged essential facilities a high level of protection through the objective test. Furthermore, it is not just the establishment of innovations protected by IPRs that demands high investments: the same is also true for tangible facilities and services, which voids the need for additional protection of IPR holders.

In my opinion, the new product condition is vague and very much open to interpretation, as it is not always clear what a new product is and whether the product in question is actually “new” or just an improvement of an existing product. What the ECJ has made clear in its case law, however, is that the new product does not have to be so new that it opens up a new market that did not exist before. The technical progress condition is, in my view, even more vague than the new product condition because it is not clear how much technical progress is required for the doctrine to apply. In other words, it is not clear whether a small amount of technical development is sufficient or whether the technical progress must be so substantial that the product is already a virtually new product.

Despite the reluctance of the ECJ and the EC to acknowledge that Big Data can be an essential facility, recent legislative developments at the EU level and in Germany confirm that this is indeed the case. The fact that Big Data may be an essential facility naturally raises the question under which of the existing criteria the character of a particular set of Big Data as an essential facility should be assessed, or whether new criteria should be developed. Since this is primarily a competition policy question rather than a competition law question, this paper has not attempted to answer it. What it did, however, was prove that neither the IMS Health nor the Microsoft criteria are suitable for application in cases where access to a set of Big Data would be demanded on grounds of the doctrine. Big Data as such are not necessarily protected by copyright. This is only the case when some form of individual creative effort, a “personal touch,” is present in the process of accumulating and/or processing the relevant data. In my view, the application of criteria specifically designed to assess whether facilities protected by either copyrights or patents are essential facilities is not justified in cases where a set of Big Data is protected by neither of them. Moreover, both in cases where Big Data is protected by copyright and in cases where it is not, the lack of its intrinsic value limits the applicability of the new product condition. The latter condition should therefore be applied only in situations where the nature of the information contained in a set of Big Data is known in advance (before it is analyzed) using advanced analytical tools, but not where this is not the case. In other words, the new product condition should not be applied where it is not possible to know whether the information contained in a set of Big Data could enable the offering of a new product before this set of Big Data is subjected to analysis with advanced algorithms, which can only be done after access has already been granted.Footnote 95 Looking ahead, since markets driven by Big Data are characterized by their dynamism and extremely rapid technical progress, it can be assumed that any product whose essential input is a set of Big Data represents at least some technical progress over the already existing product, meaning that the technical progress condition becomes obsolete.